157 filings
Page 3 of 8
8-K
t660 apft6q45zp
19 Feb 21
Departure of Directors or Certain Officers
4:30pm
8-K
apbgum1bhbn h7b5
4 Feb 21
Departure of Directors or Certain Officers
4:31pm
8-K
2m3hqvxmbuz7h5cexw92
25 Jan 21
Biostage Strengthens Board of Directors with Appointment of Herman Sanchez
8:05am
8-K
8fi36i54 9z
31 Dec 20
Other Events
12:00am
8-K
lp8st
13 Nov 20
Biostage Reports Third Quarter 2020 Financial Results
4:15pm
8-K
nlf4owh
30 Oct 20
Departure of Directors or Certain Officers
8:00am
8-K
mzo dxxnsdxm7g
2 Oct 20
Unregistered Sales of Equity Securities
12:00am
8-K
x5qs4b ibix
8 Sep 20
Departure of Directors or Certain Officers
4:15pm
8-K
z3tfab4 j1tka
31 Aug 20
Departure of Directors or Certain Officers
4:19pm
8-K
7v6fqzya37ut463b0re
20 Aug 20
Entry into a Material Definitive Agreement
4:25pm
8-K
9fkebba
13 Aug 20
Biostage Reports Second Quarter 2020 Financial Results
4:22pm
8-K
wih632qtwa11im9
1 Jul 20
Other Events
4:01pm
8-K
f0y z9e2mxz
22 Jun 20
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
zu6md gtnxgh4e
14 May 20
Biostage Reports First Quarter 2020 Financial Results
4:10pm
8-K
npyorvqv3i3nz0vs3kc
5 May 20
Entry into a Material Definitive Agreement
4:05pm
8-K
a7dkx1
30 Apr 20
Unregistered Sales of Equity Securities
4:06pm
8-K
j72khovlahitkjrc
27 Mar 20
Biostage Reports 2019 Financial Results
4:11pm
8-K
uwh66lhbxc0
24 Mar 20
Departure of Directors or Certain Officers
4:45pm
8-K
t1w3htp1atamun
20 Mar 20
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan™ Esophageal Implant
7:05am
8-K
0qbt ien2fr5a8gyg
20 Feb 20
Biostage Submitted Official Response to FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
4:05pm